Illustrating the Philadelphia region’s prowess in the rapidly expanding life sciences space, a local research hub is adding more capacity via another local research hub.
University of Pennsylvania’s Gene Therapy Program, an R&D org developing and commercializing gene-based therapeutics, is expanding to King of Prussia-based Discovery Labs.
The lease includes 150,000 square feet of lab space across two buildings in Discovery Labs’ campus. Penn’s gene therapy program will join the ranks of an “anchor tenant” along with existing tenants GSK, WuXi Biologics and The Center for Breakthrough Medicines on the biotech innovation campus.
READ FULL ARTICLE HERE
